Status:
COMPLETED
Duloxetine vs. Active Comparator in the Treatment of Patients With Depression
Lead Sponsor:
Eli Lilly and Company
Conditions:
Depression
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
How duloxetine compares to a medication currently available for the treatment of patients diagnosed with depression
Eligibility Criteria
Inclusion
- Must be at least 18 years of age
- Must be diagnosed with depression
- Must sign informed consent
- Women who can become pregnant must be using birth control
Exclusion
- Previous diagnosis of bipolar disorder, schizophrenia, or other psychotic disorder
- History of substance abuse or dependence in the last year
- Patients who are suicidal
- Frequent or severe allergic reactions with multiple medications
Key Trial Info
Start Date :
July 1 2003
Trial Type :
INTERVENTIONAL
End Date :
May 1 2004
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT00071695
Start Date
July 1 2003
End Date
May 1 2004
Last Update
May 21 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM - 5 PM Easter Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
La Rochelle, France